Researchers at Brigham and Women’s Hospital are conducting a clinical research study for adults diagnosed with Primary Sclerosing Cholangitis.
The purpose of this study is to better understand liver detoxification in individuals living with this condition. The study is conducted entirely remotely, allowing participants to take part from home through virtual visits and at-home nurse visits, while supporting important liver research.
.png){kind=icon}
The study is conducted entirely remotely, with virtual visits and at-home nurse visits for sample collection.
Adults age 18 years and older may be eligible to participate.
.png){kind=icon}
Diagnosed with Primary Sclerosing Cholangitis
.png){kind=icon}
12-week study with a total of 9 virtual study visits
.png)
This study is conducted by researchers at Brigham and Women’s Hospital.
All participation takes place remotely. Study visits are virtual, with at-home nurse visits to collect required samples.
The study lasts 12 weeks and includes a total of 9 virtual visits.
After completing a brief screening questionnaire, the study team will review your information and contact you if you may be eligible.
